UnannouncedVCInvestor

MBX Crossover Capsule

Startup rounds since 2021 with a MBX Crossover Capsule investor on the board, and the firm's own fund filings.

Raises
6
since 2021
Unannounced
3
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name

Rounds

  1. Neurofold Therapeutics Inc.$6.5MUnannounced · 64 days14 Jul 2026 · Greenwood Village, CO · Biotech
  2. Contraline, Inc.$55.8MAnnounced10 Jun 2026 · Charlottesville, VA · Biotech
  3. Junction Health, Inc.$3.54MUnannounced · 117 days22 May 2026 · Denver, CO · Health care
  4. Ancilia Biosciences, Inc.$10.1MUnannounced · 163 days6 Apr 2026 · New York, NY
  5. Contraline, Inc.$7.23MFiled before 20255 Apr 2022 · Charlottesville, VA · Biotech
  6. Attivare Therapeutics, Inc.$5.88MFiled before 202517 Dec 2021 · Natick, MA

By year

YearRaisesUnannounced
202643
20221—
20211—

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, each at its latest filing.

FundFiledSizeRaised
Mbx Crossover Capsule I, LLC26 May 2021$4.13M$4.13M

Listed because a MBX Crossover Capsule fund's filing names a director of each company. A name match is not a verified identity.